PDF herunterladen
Thromb Haemost 1979; 42(03): 1066-1068
DOI: 10.1055/s-0038-1657002
Letter to the Editor
Schattauer GmbH Stuttgart

High and Low Molecular Weight Urokinase

Gene Murano
Bureau of Biologies, FDA, 8800 Rockville Pike, Bethesda, Maryland, U.S.A.
,
David L Aronson
Bureau of Biologies, FDA, 8800 Rockville Pike, Bethesda, Maryland, U.S.A.
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. August 2018 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints
 

  • References

  • 1 Samama M, Cazenave B, Otero AM. 1978; Urokinase I and II Activity. Thrombos. Haemost 40: 578
    PubMedGoogle Scholar
  • 2 Sasahara AA, Hyers TM, Cole CM. et al 1973; The urokinase pulmonary embolism trial. Circulation suppl (Suppl. 02) 47: 1
    CrossrefPubMedGoogle Scholar
  • 3 Urokinase pulmonary embolism trial study group. 1974; Urokinasestreptokinase pulmonary embolism trial. J.A.M.A. 229: 1606
    CrossrefPubMedGoogle Scholar
  • 4 Sasahara AA, Bell WR, Simon TL, Stengle JM, Sherry S. 1975; Phase II Urokinasestreptokinase pulmonary embolism trial. Thrombos. Diathes. Haemorrh. 33: 464
    PubMedGoogle Scholar
  • 5 Vahtera E, Hamberg U. 1978; Interaction of urokinase with a-macroglobulin investigated by isoelectric focusing. Biochem. J 171: 767
    CrossrefPubMedGoogle Scholar
  • 6 Clemmensen I, Christensen F. 1976; Inhibition of urokinase by complex formation with human α1-antitrypsin. Biochim. Biophys. Acta 429: 591
    CrossrefPubMedGoogle Scholar
  • 7 Clemmensen I. 1978; Inhibition of urokinase by complex formation with human antithrombin III in presence and absence of heparin. Thromb. Haemostas 39: 616
    PubMedGoogle Scholar